MARKET

TNDM

TNDM

Tandem Diabetes
NASDAQ
31.11
+0.68
+2.22%
Opening 12:05 04/22 EDT
OPEN
30.65
PREV CLOSE
30.43
HIGH
31.19
LOW
30.12
VOLUME
321.53K
TURNOVER
0
52 WEEK HIGH
42.09
52 WEEK LOW
13.82
MARKET CAP
2.01B
P/E (TTM)
-9.0780
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TNDM last week (0415-0419)?
Weekly Report · 4h ago
TNDM Crosses Above Average Analyst Target
NASDAQ · 5d ago
Weekly Report: what happened at TNDM last week (0408-0412)?
Weekly Report · 04/15 11:18
Press Release: Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024. The Company will hold a conference call and simultaneous webcast to discuss its first quarter 2024 financial and operating results after the financial markets close. Tandem is a leading insulin delivery and diabetes technology company.
Dow Jones · 04/09 20:12
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Tandem Diabetes Care, Inc. Plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast to discuss its financial and operating results. A live webcast of the call will be available on the company's Investor Center website.
Barchart · 04/09 15:05
Weekly Report: what happened at TNDM last week (0401-0405)?
Weekly Report · 04/08 11:23
What 4 Analyst Ratings Have To Say About Tandem Diabetes Care
Tandem Diabetes Care (NASDAQ:TNDM) has an average price target of $32.5. The company designs, manufactures, and markets durable insulin pumps for diabetes patients. 4 analysts have recently shared their insights on Tandem diabetes care. The firm has a 12-month price target for the company with an average of $24.25.
Benzinga · 04/03 20:00
Tandem Diabetes Care Price Target Raised to $38.00/Share From $31.00 by Citigroup
Dow Jones · 04/03 18:45
More
About TNDM
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Webull offers Tandem Diabetes Care Inc stock information, including NASDAQ: TNDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNDM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNDM stock methods without spending real money on the virtual paper trading platform.